Innovative Kidney Transplant Matching Method Promises Improved Long-Term Success
A new method utilizing SIRP-alpha matching alongside traditional HLA testing may enhance long-term kidney transplant success by better predicting rejection risks.
Researchers at the University of Pittsburgh have developed a groundbreaking technique to better predict compatibility between kidney donors and recipients, potentially enhancing transplant longevity. Traditionally, kidney matching relies heavily on assessing human leukocyte antigens (HLA), which serve as genetic fingerprints that help the immune system distinguish between self and non-self. While good HLA matching reduces rejection risk, it does not eliminate the need for lifelong immunosuppression and has limited progress in advancing transplant outcomes.
The new approach focuses on the role of a cell surface receptor called SIRP-alpha, found on innate immune cells called monocytes. Building on earlier animal studies, scientists have identified that mismatches in SIRP-alpha variants between donor and recipient can increase the likelihood of early rejection, scarring, and overall graft failure. This finding was confirmed through extensive genomic analysis of thousands of human donor-recipient pairs, demonstrating that mismatched SIRP-alpha types, labeled as A and B, correlate with poorer transplant results.
Implementing SIRP-alpha testing alongside traditional HLA matching could serve as an additional tool to assess rejection risks more accurately. This personalized method may help identify patients who could benefit from intensified immunosuppressive therapies, ultimately aiming to extend the lifespan of kidney transplants. The research team at Pitt is now exploring whether targeting monocytes with specific therapeutics, such as corticosteroids, may mitigate rejection risks associated with SIRP-alpha mismatches.
These advancements move closer to the goal of achieving transplanted kidney longevity and reducing organ scarcity by improving success rates. The findings were published in Science Translational Medicine and underscore the importance of personalized immunosuppression strategies in transplant medicine.
Source: https://medicalxpress.com/news/2025-07-approach-kidney-transplant-term-outcomes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Impact of Safety Standards on Reducing Quad Bike Fatalities in Australia Since 2019
Recent Australian research shows a modest decline in work-related quad bike deaths since 2019 safety standards were introduced, highlighting the importance of safety enforcement and helmet use on farms.
FDA Issues Urgent Alert Over Salmonella-Contaminated Tomatoes in Three Southern States
The FDA has issued a top-level recall for tomatoes contaminated with Salmonella in Georgia, North Carolina, and South Carolina, highlighting potential severe health risks. Learn more about this urgent warning and how to stay safe.
Understanding the Rise in Measles Cases and How to Prevent Them
The U.S. faces its largest measles outbreak in over 30 years due to declining vaccination rates. Experts highlight airborne transmission and stress the importance of community vaccination to stop the spread.
Innovative Gene-Editing Platform Enhances Anti-Cancer Immunotherapy Safety and Effectiveness
A groundbreaking gene-editing platform enhances the safety and effectiveness of T cell–based cancer immunotherapies by enabling tumor-specific drug production, reducing side effects and boosting anti-cancer responses.